EMA panel recommends against Portola's clot prevention drug
(Reuters) - A panel of European Medicines Agency on Friday recommended against granting marketing approval to Portola Pharmaceuticals Inc's oral blood thinner, saying the benefits of the drug did not outweigh risks.
from Reuters: Health News http://reut.rs/2IMt0Hk
http://bit.ly/2zwRqiM